CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 200 enrolled
Drug / intervention
coronary interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01031095
NCT01031095Phase 3Completed
CompareCT.gov

A RandomisED StUdy Comparing Standard Systemic Anticoagulation ThErapy to Low Dose Intracoronary Anticoagulation Therapy for Elective Percutaneous Coronary Intervention

Bursa Postgraduate Hospital·interventional·Posted Dec 14, 2009·Updated Jan 30, 2014

In Brief

A Phase 3 clinical trial evaluating coronary intervention for Coronary Artery Disease. Completed, enrolled 200 participants across 1 site.

Detailed Summary

The hypothesis: Low dose intracoronary unfractionated heparin is as effective and safe as standard dose intravenous unfractionated heparin on patients with elective percutaneous coronary intervention.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
CountriesTurkey (Türkiye)
Collaborators--

Timeline

Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 14, 2009
Enrollment StartJun 1, 2009
Primary CompletionDec 1, 2009
Study CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 16.6 years ago

Interventions

coronary interventionother

elective coronary intervention